Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2010

01-12-2010 | Original Article

The Association of Inflammatory Bowel Disease and Mediterranean Fever Gene (MEFV) Mutations in Turkish Children

Authors: Nuray Uslu, Aysel Yüce, Hülya Demir, Inci N. Saltik-Temizel, Yusuf Usta, Engin Yilmaz, Nesrin Beşbaş, Figen Gürakan, Hasan Özen, Seza Özen

Published in: Digestive Diseases and Sciences | Issue 12/2010

Login to get access

Abstract

Background and Aims

Familial Mediterranean fever (FMF) and inflammatory bowel disease (IBD) concordance has been investigated in a few studies. We investigated MEFV mutations and prevalence of FMF disease in Turkish children with IBD and their relationship with the disease severity.

Methods

Sixteen patients with ulcerative colitis (UC), 14 with Crohn’s disease (CD) and three with indeterminate colitis (IC) were enrolled in the study (median age 13 years, range 0.6–16 years, n = 19 boys). Demographic, clinical and laboratory characteristics of the patients were evaluated as well as the parameters of disease severity. All patients were screened for 12 common MEFV mutations.

Results

MEFV mutations were detected in 17 of 66 (25.7%) alleles. Seven patients (four patients with CD, two with IC, and one with UC) were also diagnosed as FMF. FMF disease was found in seven of all IBD patients (21.2%) and four of them had CD. M694V was the leading mutation, and as a disease-causing mutation, it was found to be significantly more frequent in CD patients than UC patients (Fisher’s exact test P = 0.03). Demographics, laboratory evaluations, growth parameters, extraintestinal manifestations, and treatment with immunosuppressive agents other than steroids were comparable between the patients with and without FMF in most aspects.

Conclusions

Although this is a small cohort, disease-causing MEFV mutations and FMF disease rate were increased among our patients with IBD. The increase was prominent among CD patients, whereas in UC the rate was similar to the Turkish healthy control population.
Literature
1.
go back to reference Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol. 2008;14:413–420.CrossRefPubMed Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol. 2008;14:413–420.CrossRefPubMed
2.
go back to reference Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD-2 leucine rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.CrossRefPubMed Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD-2 leucine rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.CrossRefPubMed
3.
go back to reference Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.CrossRefPubMed Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.CrossRefPubMed
4.
go back to reference Barrett JC, Hansoul S, Nicolae D, et al. Genome-wide association defines more than thirty distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40:955–962.CrossRefPubMed Barrett JC, Hansoul S, Nicolae D, et al. Genome-wide association defines more than thirty distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40:955–962.CrossRefPubMed
5.
go back to reference Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–1885.CrossRefPubMed Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–1885.CrossRefPubMed
6.
go back to reference Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162:449–454.CrossRefPubMed Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162:449–454.CrossRefPubMed
7.
go back to reference Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis. 2009;68:246–248.CrossRefPubMed Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis. 2009;68:246–248.CrossRefPubMed
8.
go back to reference Ozen S, Hoffman HM, Frenkerl J, Kastner D. Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth international congress on the systemic autoinflammatory disease held in Bethesda, USA, 6–10 November 2005. Ann Rheum Dis. 2006;65:961–964.CrossRefPubMed Ozen S, Hoffman HM, Frenkerl J, Kastner D. Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth international congress on the systemic autoinflammatory disease held in Bethesda, USA, 6–10 November 2005. Ann Rheum Dis. 2006;65:961–964.CrossRefPubMed
9.
go back to reference Turkish FMF study group. Familial Mediterranean fever (FMF) disease in Turkey. Medicine. 2005;84:1–11.CrossRef Turkish FMF study group. Familial Mediterranean fever (FMF) disease in Turkey. Medicine. 2005;84:1–11.CrossRef
10.
go back to reference Yilmaz E, Ozen S, Balci B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet. 2001;9:553–555.CrossRefPubMed Yilmaz E, Ozen S, Balci B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet. 2001;9:553–555.CrossRefPubMed
11.
go back to reference Ayaz NA, Ozen S, Bilginer Y, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology. 2009;48:23–25.CrossRefPubMed Ayaz NA, Ozen S, Bilginer Y, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology. 2009;48:23–25.CrossRefPubMed
12.
go back to reference Cattan D, Notarnicola C, Molinari N, Touitou I. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet. 2000;355:378–379.CrossRefPubMed Cattan D, Notarnicola C, Molinari N, Touitou I. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet. 2000;355:378–379.CrossRefPubMed
13.
go back to reference Fidder HH, Chowers Y, Ackerman Z, et al. The familial Mediterranean fever (MEFV) gene as a modifier of Crohn’s disease. Am J Gatroenterol. 2005;100:338–343.CrossRef Fidder HH, Chowers Y, Ackerman Z, et al. The familial Mediterranean fever (MEFV) gene as a modifier of Crohn’s disease. Am J Gatroenterol. 2005;100:338–343.CrossRef
14.
go back to reference Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A. Crohn's disease in patients with familial Mediterranean fever. Medicine. 2002;81:411–416.CrossRefPubMed Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A. Crohn's disease in patients with familial Mediterranean fever. Medicine. 2002;81:411–416.CrossRefPubMed
15.
go back to reference Giaglis S, Mimidis K, Papadopoulos V, et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci. 2006;51:687–692.CrossRefPubMed Giaglis S, Mimidis K, Papadopoulos V, et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci. 2006;51:687–692.CrossRefPubMed
16.
go back to reference Ozen S, Bakkaloglu A, Yilmaz E, et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheum. 2003;30:2014–2018.PubMed Ozen S, Bakkaloglu A, Yilmaz E, et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheum. 2003;30:2014–2018.PubMed
17.
go back to reference Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr. 2006;167:391–393.CrossRef Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr. 2006;167:391–393.CrossRef
18.
go back to reference Yurtcu E, Gokcan H, Yilmaz U, Sahin FI. Detection of MEFV gene mutations in patients with inflammatory bowel disease. Genet Test Mol Biomarkers. 2009;13:87–90.CrossRefPubMed Yurtcu E, Gokcan H, Yilmaz U, Sahin FI. Detection of MEFV gene mutations in patients with inflammatory bowel disease. Genet Test Mol Biomarkers. 2009;13:87–90.CrossRefPubMed
19.
go back to reference Ben-Chetrit E, Backenroth R. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis. 2001;60:146–149.CrossRefPubMed Ben-Chetrit E, Backenroth R. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis. 2001;60:146–149.CrossRefPubMed
20.
go back to reference The French FMF. Consortium: a candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.CrossRef The French FMF. Consortium: a candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.CrossRef
21.
go back to reference The International FMF Consortium. Ancient missense mutations in a new member of RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.CrossRef The International FMF Consortium. Ancient missense mutations in a new member of RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.CrossRef
22.
go back to reference Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 modulate IL-1 beta production. Proc Natl Acad Sci USA. 2006;103:9982–9987.CrossRefPubMed Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 modulate IL-1 beta production. Proc Natl Acad Sci USA. 2006;103:9982–9987.CrossRefPubMed
23.
go back to reference Kalyoncu M, Acar BC, Cakar N, et al. Are carriers for MEFV mutations “healthy”? Clin Exp Rheumatol. 2006;24:120–122. Kalyoncu M, Acar BC, Cakar N, et al. Are carriers for MEFV mutations “healthy”? Clin Exp Rheumatol. 2006;24:120–122.
24.
go back to reference IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis—the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1–7.CrossRef IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis—the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1–7.CrossRef
25.
go back to reference North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition: Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn’s disease in children and young adults: report of a working group of the North American society for pediatric gastroenterology, hepatology and the Crohn’s and colitis foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.CrossRefPubMed North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition: Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn’s disease in children and young adults: report of a working group of the North American society for pediatric gastroenterology, hepatology and the Crohn’s and colitis foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.CrossRefPubMed
26.
go back to reference Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447.PubMed Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447.PubMed
27.
go back to reference Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423–432.CrossRefPubMed Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423–432.CrossRefPubMed
28.
go back to reference Yalcinkaya F, Ozcakar ZB, Kasapcopur O, et al. Prevalence of MEFV gene mutations in childhood polyarteris nodosa. J Pediatr. 2007;151:675–678.CrossRefPubMed Yalcinkaya F, Ozcakar ZB, Kasapcopur O, et al. Prevalence of MEFV gene mutations in childhood polyarteris nodosa. J Pediatr. 2007;151:675–678.CrossRefPubMed
29.
go back to reference Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol. 2008;4:34–42.CrossRefPubMed Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol. 2008;4:34–42.CrossRefPubMed
30.
go back to reference Gershoni Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr. 2003;143:658–661.CrossRefPubMed Gershoni Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr. 2003;143:658–661.CrossRefPubMed
Metadata
Title
The Association of Inflammatory Bowel Disease and Mediterranean Fever Gene (MEFV) Mutations in Turkish Children
Authors
Nuray Uslu
Aysel Yüce
Hülya Demir
Inci N. Saltik-Temizel
Yusuf Usta
Engin Yilmaz
Nesrin Beşbaş
Figen Gürakan
Hasan Özen
Seza Özen
Publication date
01-12-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1178-5

Other articles of this Issue 12/2010

Digestive Diseases and Sciences 12/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine